Skip to main content
. 2004 Nov 15;114(10):1444–1456. doi: 10.1172/JCI21689

Figure 6.

Figure 6

Effects of intracolonic (i.c.) administration of PAR1-activating peptide TFLLR-NH2, control peptide RLLFT-NH2, or their vehicle (saline) on weight (A), macroscopic-damage score (B), and MPO activity (C), in C57BL/6 mice that have received an intracolonic administration of TNBS (1 mg/mouse in 40% ethanol). Values are mean ± SEM; n = 10 per group. *Significantly different from RLLFT-NH2–treated group.